To our knowledge, this is the first study that considers the two different lncRNA (ANRIL and UFC1) and one miRNA (miR-34a) and unveils the new regulatory role of miR-34a in NSCLC. This evidence concerns the gene CDKN2B-AS1 and non-small cell lung carcinoma.